Rosetta Genomics Ltd
OTC:ROSGQ
Balance Sheet
Balance Sheet Decomposition
Rosetta Genomics Ltd
Current Assets | 5.7m |
Cash & Short-Term Investments | 1.3m |
Receivables | 987k |
Other Current Assets | 3.4m |
Non-Current Assets | 527k |
PP&E | 522k |
Other Non-Current Assets | 5k |
Current Liabilities | 2.7m |
Accounts Payable | 2m |
Other Current Liabilities | 713k |
Non-Current Liabilities | 2.4m |
Long-Term Debt | 37k |
Other Non-Current Liabilities | 2.4m |
Balance Sheet
Rosetta Genomics Ltd
Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
14
|
14
|
3
|
3
|
1
|
31
|
17
|
8
|
12
|
6
|
|
Cash Equivalents |
14
|
14
|
3
|
3
|
1
|
31
|
17
|
8
|
12
|
6
|
|
Short-Term Investments |
8
|
1
|
6
|
1
|
0
|
0
|
8
|
8
|
0
|
0
|
|
Total Receivables |
0
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
6
|
3
|
|
Accounts Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
2
|
0
|
|
Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
Total Current Assets |
22
|
17
|
11
|
4
|
1
|
32
|
25
|
16
|
19
|
10
|
|
PP&E Net |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
2
|
|
PP&E Gross |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
2
|
|
Accumulated Depreciation |
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Goodwill |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Note Receivable |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
26
N/A
|
20
-23%
|
13
-37%
|
5
-58%
|
2
-61%
|
33
+1 491%
|
26
-20%
|
17
-33%
|
22
+30%
|
12
-47%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
|
Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
2
|
3
|
2
|
3
|
2
|
1
|
2
|
2
|
3
|
4
|
|
Long-Term Debt |
0
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Minority Interest |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
1
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
4
|
|
Total Liabilities |
2
N/A
|
4
+67%
|
6
+46%
|
7
+14%
|
2
-64%
|
2
-32%
|
2
+38%
|
2
-2%
|
3
+27%
|
8
+169%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
|
Retained Earnings |
35
|
45
|
61
|
76
|
85
|
96
|
108
|
123
|
140
|
157
|
|
Additional Paid In Capital |
59
|
61
|
68
|
75
|
85
|
125
|
130
|
136
|
157
|
157
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
24
N/A
|
16
-32%
|
7
-58%
|
1
N/A
|
0
+75%
|
31
N/A
|
24
-24%
|
15
-36%
|
20
+30%
|
4
-77%
|
|
Total Liabilities & Equity |
26
N/A
|
20
-23%
|
13
-37%
|
5
-58%
|
2
-61%
|
33
+1 491%
|
26
-20%
|
17
-33%
|
22
+30%
|
12
-47%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|